EPO906 in Carcinoid and Other Neuroendocrine Tumors

计划入组 33 人 · 首次发布于 2002 年 12 月 5 日

Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors

计划入组 45 人 · 首次发布于 2004 年 8 月 2 日

A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors

计划入组 31 人 · 首次发布于 2006 年 5 月 22 日

Octreotide(Bynfezia, Mycapssa, Sandostatin)

Rx

solid tumors therapy

anti-mesothelin + anti-CD40 CAR T-cell therapy (metastatic solid tumors)

CNS Pharmaceuticals

United States

Iovance Biotherapeutics

United States

Cellectar BioSciences

United States

Viatris Achieves Four Major Regulatory Milestones Across Diverse Pipeline Including Gene Therapy and Generic Approvals

Lutetium Lu 177 Dotatate Shows Promise in Metastatic Bronchopulmonary Neuroendocrine Tumors

Genentech Advances RO-7759065 Development for Metastatic Solid Tumors